Terms: = Prostate cancer AND SFPQ, PSF, 6421, ENSG00000116560, P23246
24 results:
1. Role of RNA binding proteins of the
Takeiwa T; Ikeda K; Horie K; Inoue S
RNA Biol; 2024 Jan; 21(1):1-17. PubMed ID: 38551131
[TBL] [Abstract] [Full Text] [Related]
2. Remodeling oncogenic transcriptomes by small molecules targeting NONO.
Kathman SG; Koo SJ; Lindsey GL; Her HL; Blue SM; Li H; Jaensch S; Remsberg JR; Ahn K; Yeo GW; Ghosh B; Cravatt BF
Nat Chem Biol; 2023 Jul; 19(7):825-836. PubMed ID: 36864190
[TBL] [Abstract] [Full Text] [Related]
3. Changes in prostate cancer survival among insured patients in relation to USPSTF screening recommendations.
Kim IE; Kim DD; Kim S; Ma S; Jang TL; Singer EA; Ghodoussipour S; Kim IY
BMC Urol; 2022 Jun; 22(1):91. PubMed ID: 35752822
[TBL] [Abstract] [Full Text] [Related]
4. LncRNA nuclear-enriched abundant transcript 1 shuttled by prostate cancer cells-secreted exosomes initiates osteoblastic phenotypes in the bone metastatic microenvironment via miR-205-5p/runt-related transcription factor 2/splicing factor proline- and glutamine-rich/polypyrimidine tract-binding protein 2 axis.
Mo C; Huang B; Zhuang J; Jiang S; Guo S; Mao X
Clin Transl Med; 2021 Aug; 11(8):e493. PubMed ID: 34459124
[TBL] [Abstract] [Full Text] [Related]
5. Targeting Epigenetic and Posttranscriptional Gene Regulation by psf Impairs Hormone Therapy-Refractory cancer Growth.
Takayama KI; Honma T; Suzuki T; Kondoh Y; Osada H; Suzuki Y; Yoshida M; Inoue S
Cancer Res; 2021 Jul; 81(13):3495-3508. PubMed ID: 33975881
[TBL] [Abstract] [Full Text] [Related]
6. Repeatability of Quantitative
Jansen BHE; Cysouw MCF; Vis AN; van Moorselaar RJA; Voortman J; Bodar YJL; Schober PR; Hendrikse NH; Hoekstra OS; Boellaard R; Oprea-Lager DE
J Nucl Med; 2020 Sep; 61(9):1320-1325. PubMed ID: 31924729
[TBL] [Abstract] [Full Text] [Related]
7. Regularized reconstruction of digital time-of-flight
Lindström E; Velikyan I; Regula N; Alhuseinalkhudhur A; Sundin A; Sörensen J; Lubberink M
Theranostics; 2019; 9(12):3476-3484. PubMed ID: 31281491
[TBL] [Abstract] [Full Text] [Related]
8. Splicing Factors Have an Essential Role in prostate cancer Progression and Androgen Receptor Signaling.
Takayama KI
Biomolecules; 2019 Apr; 9(4):. PubMed ID: 30939845
[TBL] [Abstract] [Full Text] [Related]
9. AR-V7 in circulating tumor cells cluster as a predictive biomarker of abiraterone acetate and enzalutamide treatment in castration-resistant prostate cancer patients.
Okegawa T; Ninomiya N; Masuda K; Nakamura Y; Tambo M; Nutahara K
Prostate; 2018 Jun; 78(8):576-582. PubMed ID: 29508425
[TBL] [Abstract] [Full Text] [Related]
10. Bayesian penalised likelihood reconstruction (Q.Clear) of
Teoh EJ; McGowan DR; Schuster DM; Tsakok MT; Gleeson FV; Bradley KM
Br J Radiol; 2018 May; 91(1085):20170727. PubMed ID: 29303359
[TBL] [Abstract] [Full Text] [Related]
11. Dysregulation of spliceosome gene expression in advanced prostate cancer by RNA-binding protein psf.
Takayama KI; Suzuki T; Fujimura T; Yamada Y; Takahashi S; Homma Y; Suzuki Y; Inoue S
Proc Natl Acad Sci U S A; 2017 Sep; 114(39):10461-10466. PubMed ID: 28893982
[TBL] [Abstract] [Full Text] [Related]
12. Optimal combination of anti-scatter grids and software correction for CBCT imaging.
Stankovic U; Ploeger LS; van Herk M; Sonke JJ
Med Phys; 2017 Sep; 44(9):4437-4451. PubMed ID: 28556204
[TBL] [Abstract] [Full Text] [Related]
13. Study of Splicing Factor, Proline- and Glutamine-rich by Proteomic Techniques in Human Malignant and Nonmalignant Cell Lines.
Pashintseva NV; Shishkin SS; Lisitskaya KV; Kovalev LI; Kovaleva MA; Eryomina LS; Kamenikhina IA; Novikova LA; Sadykhov EG
Protein Pept Lett; 2016; 23(11):958-966. PubMed ID: 27633854
[TBL] [Abstract] [Full Text] [Related]
14. Xp11 neoplasm with melanocytic differentiation of the prostate harbouring the novel NONO-TFE3 gene fusion: report of a unique case expanding the gene fusion spectrum.
Wang XT; Xia QY; Ni H; Wang ZY; Ye SB; Li R; Wang X; Lv JH; Shi SS; Ma HH; Lu ZF; Shen Q; Zhou XJ; Rao Q
Histopathology; 2016 Sep; 69(3):450-8. PubMed ID: 26844676
[TBL] [Abstract] [Full Text] [Related]
15. Multimodal Partial-Volume Correction: Application to 18F-Fluoride PET/CT Bone Metastases Studies.
Grecchi E; O'Doherty J; Veronese M; Tsoumpas C; Cook GJ; Turkheimer FE
J Nucl Med; 2015 Sep; 56(9):1408-14. PubMed ID: 26182970
[TBL] [Abstract] [Full Text] [Related]
16. ARCHERRT - a GPU-based and photon-electron coupled Monte Carlo dose computing engine for radiation therapy: software development and application to helical tomotherapy.
Su L; Yang Y; Bednarz B; Sterpin E; Du X; Liu T; Ji W; Xu XG
Med Phys; 2014 Jul; 41(7):071709. PubMed ID: 24989378
[TBL] [Abstract] [Full Text] [Related]
17. An integrative proteomics and interaction network-based classifier for prostate cancer diagnosis.
Jiang FN; He HC; Zhang YQ; Yang DL; Huang JH; Zhu YX; Mo RJ; Chen G; Yang SB; Chen YR; Zhong WD; Zhou WL
PLoS One; 2013; 8(5):e63941. PubMed ID: 23737958
[TBL] [Abstract] [Full Text] [Related]
18. Androgen-responsive long noncoding RNA CTBP1-AS promotes prostate cancer.
Takayama K; Horie-Inoue K; Katayama S; Suzuki T; Tsutsumi S; Ikeda K; Urano T; Fujimura T; Takagi K; Takahashi S; Homma Y; Ouchi Y; Aburatani H; Hayashizaki Y; Inoue S
EMBO J; 2013 Jun; 32(12):1665-80. PubMed ID: 23644382
[TBL] [Abstract] [Full Text] [Related]
19. Investigation of the psf-choice method for reduced lipid contamination in prostate MR spectroscopic imaging.
Panych LP; Roebuck JR; Chen NK; Tang Y; Madore B; Tempany CM; Mulkern RV
Magn Reson Med; 2012 Nov; 68(5):1376-82. PubMed ID: 22648701
[TBL] [Abstract] [Full Text] [Related]
20. A pp32-retinoblastoma protein complex modulates androgen receptor-mediated transcription and associates with components of the splicing machinery.
Adegbola O; Pasternack GR
Biochem Biophys Res Commun; 2005 Aug; 334(2):702-8. PubMed ID: 16009334
[TBL] [Abstract] [Full Text] [Related]
[Next]
